TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO. Stock

Certificat

DE000SD4MA35

Market Closed - Boerse Frankfurt Warrants 03:48:31 2024-06-14 pm EDT
5.27 EUR +0.38% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO.
Current month+8.88%
1 month+0.96%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-14 5.27 +0.38%
24-06-13 5.25 -1.50%
24-06-12 5.33 -3.27%
24-06-11 5.51 +0.92%
24-06-10 5.46 +1.87%

Real-time Boerse Frankfurt Warrants

Last update June 14, 2024 at 03:48 pm EDT

More quotes

Static data

Product typeWarrant Knock-Out senza Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SD4MA3
ISINDE000SD4MA35
Date issued 2021-03-12
Strike 73.17 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.86
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.61
Lowest since issue 0.63

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.5 USD
Average target price
142.7 USD
Spread / Average Target
+10.20%
Consensus